What Is Margination and How Does It Work in the Body?

Margination is the process by which certain blood cells and particles drift from the center of a blood vessel toward its walls during normal circulation. White blood cells and platelets are the most familiar passengers that undergo margination, and the phenomenon is driven largely by the behavior of the far more numerous red blood cells flowing alongside them. Rather than being a passive accident, margination is a finely tuned physical process that the body relies on for immune defense and wound repair, and it has become a subject of intense interest in drug delivery and diagnostics.

How Red Blood Cells Push Everything Else to the Side

Blood is not a uniform liquid. Red blood cells make up roughly 40 to 45 percent of blood volume in a healthy adult, and they are highly deformable, bending and squeezing as they travel through vessels. In flowing blood, red blood cells tend to migrate toward the center of the vessel, forming a dense core. This inward migration happens because their flexible membranes allow them to change shape in response to flow gradients, and their equilibrium position correlates with the energy required to deform their membranes.¹ The result is a two-phase arrangement: a red-blood-cell-rich core in the middle and a relatively cell-free plasma layer hugging the vessel wall.

White blood cells and platelets, which are stiffer and shaped differently from red blood cells, do not share this inward tendency. Instead, they get crowded out. As red blood cells cluster in the center, they generate lateral forces that nudge other particles outward. In the case of white blood cells, which are larger and more rigid, the effect is especially pronounced: the collective jostling of red blood cells physically displaces them toward the wall.² Platelets, being tiny and stiff compared to red blood cells, follow a similar outward path. The net outcome is that cells the body needs at vessel walls for immune surveillance and clot formation end up concentrated exactly where they are needed.

What Determines How Strongly Margination Occurs

Margination is not an all-or-nothing event. Its strength depends on several interacting factors, and changing any one of them can dial it up or down.

Hematocrit, the proportion of blood that is red blood cells, is one of the most important variables. Higher hematocrit means more red blood cells competing for space in the vessel center, which intensifies the outward push on other particles. Both computational simulations and microfluidic experiments confirm that raising hematocrit increases the rate and degree of margination.³ Laboratory experiments in microchannels have shown that margination largely completes within about one centimeter of downstream travel and that higher hematocrit speeds this process up.⁴ This matters clinically because conditions that lower hematocrit, such as severe anemia, could weaken margination and potentially slow the body’s ability to deliver white blood cells and platelets to where they are needed.

Vessel size also plays a role. Margination is most relevant in the microcirculation, the network of tiny vessels where arterioles, capillaries, and venules carry blood at close quarters. Simulations show that the distance a particle needs to travel before it reaches the wall increases steeply with vessel diameter, roughly in proportion to the cube of the channel height.⁵ In large arteries, where the vessel is wide and the red-blood-cell core is far from the walls, the same physical forces still exist, but the margination effect is diluted. In the smallest vessels, the geometry squeezes everything together, and margination becomes a dominant feature of the flow.

The stiffness and size of the marginating cell matter as well. White blood cells marginate effectively in part because they are relatively rigid compared to red blood cells. But paradoxically, making white blood cells even more deformable reduces their tendency to marginate, because they can slip through gaps in the red-blood-cell core rather than being expelled from it.² This interplay between stiffness and margination becomes especially relevant in disease states that alter cell rigidity.

Why the Body Needs Cells at the Wall

Margination is not just a curiosity of fluid physics. The body uses it to solve two critical problems: stopping bleeding and fighting infection.

For clot formation, platelets need to be near the vessel wall so they can detect damage and stick to exposed tissue. The fluid dynamics of blood flow have evolved to keep platelets concentrated in the near-wall plasma layer, where they are primed to respond to injury.⁶ Without margination, platelets would be scattered evenly throughout the bloodstream, and their ability to rapidly seal a wound would be severely compromised. The near-wall excess of platelet-sized particles has been measured at several times the average concentration, reaching levels around three to four times higher near the wall in microchannels, and this excess grows with increasing flow rate.⁷

For immune defense, white blood cells undergo a sequence of steps when responding to inflammation or infection: margination toward the wall, rolling along the endothelial surface, firm adhesion, and finally emigration out of the vessel into the surrounding tissue. Margination is the physical precondition for all of the steps that follow. This cascade is mediated by adhesion molecules on the inner surface of postcapillary venules, and it is recognized as one of the key early steps in the inflammatory response.⁸ If white blood cells did not marginate, they would sail past inflamed tissue without ever making contact with the vessel wall and without ever leaving the bloodstream.

Interactions between red blood cells and a white blood cell already near the wall go beyond simple displacement. Simulations of red blood cells flowing past a wall-bound leukocyte show that red cells exert an average force that pushes the white cell toward the wall, helping to reinforce binding once contact is made.⁹ Red blood cell aggregation, the tendency of red cells to stack together in low-flow conditions, further enhances white blood cell margination by creating larger red-cell clusters that more forcefully exclude other cell types from the center.²

How Vessel Shape Changes the Rules

Blood vessels are not perfectly round tubes. They branch, curve, and have cross-sections that range from circular to elliptical to irregularly shaped. These geometric details affect where marginating cells end up.

Vessel cross-section shape influences the direction of the forces acting on cells. In vessels with angular or irregular cross-sections, the shear rate gradients near corners can point in unexpected directions. When a red blood cell sits near a boundary with an obtuse angle, the forces push it back toward the center. But near a sharp corner, the forces reverse and push cells into the corner instead.¹⁰ This means that stiffened or abnormal red blood cells can accumulate unevenly depending on the local shape of the vessel, rather than distributing smoothly along the entire wall.

At vessel branch points, the story is a little different. You might expect that abrupt geometry changes at bifurcations would scramble the margination pattern, but research suggests that at true bifurcations, margination is largely unaffected by the geometry. The disruption happens more at side branches and confluences, where flow patterns can temporarily reverse margination for microparticles and platelets.¹¹ This “antimargination” effect near branch points is a reminder that the neat textbook picture of cells drifting smoothly to the wall plays out differently in the complex three-dimensional geometry of real vasculature.

When Margination Goes Wrong in Disease

Because margination depends on the physical properties of cells, diseases that change those properties can dramatically alter the process.

Malaria offers one of the most studied examples. The parasite Plasmodium falciparum invades red blood cells and makes them progressively stiffer as the infection matures inside the cell. In normal blood, healthy red blood cells migrate to the center because of their deformability. But as infected red blood cells become rigid, they lose this centering tendency and instead get pushed toward the vessel wall through the same margination forces that act on white blood cells. Simulations show that even at an intermediate infection stage, infected cells still have enough residual deformability for some inward migration, but the hydrodynamic interaction with surrounding healthy red blood cells overwhelms this and drives them to marginate.¹² Laboratory experiments using engineered capillaries confirm that infected red blood cells show virtually no deformation and rapidly accumulate in narrow regions.¹³ This margination of infected cells to the vessel wall promotes their adhesion to the endothelium, contributing to the vascular obstruction that makes severe malaria dangerous.

Beyond malaria, other blood disorders produce abnormal red blood cells that are smaller or stiffer than normal, such as those seen in sickle cell disease and other inherited anemias. Computational modeling shows that these aberrant red blood cells concentrate near vessel walls due to their physical contrast with normal cells. In curved or geometrically complex vessels, they distribute unevenly, and their repeated contact with the vessel wall generates large transient stress fluctuations on the endothelium. This offers a mechanical explanation for the vascular inflammation commonly observed in hematologic disorders: even without immune signaling, the physical pounding of abnormal cells against the vessel wall may damage it.¹⁴

Designing Drug Carriers That Exploit Margination

If the body naturally pushes certain particles toward vessel walls, then drug delivery particles engineered to mimic those physical properties should do the same. This idea has driven significant research into how the size, shape, and stiffness of drug carriers affect their margination in blood flow.

The general finding is that particle design choices matter enormously. Larger, stiffer, and non-spherical particles tend to marginate more effectively than small, soft, spherical ones.¹⁵ Computational and experimental studies have shown that micro-scale non-spherical particles undergo enhanced margination and adhesion compared to nano-scale spherical particles, resulting in higher binding to the vessel wall.¹⁶ This runs somewhat counter to the historical preference for very small spherical nanoparticles in drug delivery. The implication is that a disc-shaped or rod-shaped microparticle might actually reach the vessel wall faster and stick better than a conventional spherical nanoparticle, at least under certain blood flow conditions.

The challenge is balancing margination against other requirements. A particle that marginate well but is too rigid may trigger an immune response or get trapped prematurely. A particle that is too large may not circulate through the smallest capillaries. So the engineering problem is not simply “maximize margination” but rather “marginate enough, in the right vessels, without causing harm.” Microfluidic devices that mimic blood flow conditions have become critical tools for testing these trade-offs before moving to animal models.

Margination in Medical Devices and Extracorporeal Circuits

Margination is not only a concern inside the body. Whenever blood flows through artificial tubing and devices, the same physics applies, and the consequences can be harmful.

In hemodialysis, blood passes through external circuits and dialysis membranes. During this process, white blood cells can marginate and transiently stick to the surfaces of the circuit, mediated in part by the interaction between P-selectin and its ligand on white cells.¹⁷ This transient margination contributes to the well-known drop in white blood cell counts that occurs during the early minutes of a hemodialysis session. The cells are not destroyed; they temporarily stick to device surfaces and re-enter circulation once the adhesion signals wane.

In artificial hearts, ventricular assist devices, and similar blood-contacting implants, platelet margination creates a thrombosis risk. Even at the very high shear stresses found in these devices, which are far above physiological levels, platelet-sized particles still marginate and concentrate near surfaces. Experiments in microchannels at shear stresses up to about 193 pascals showed a near-wall excess of platelet-sized particles reaching roughly nine times the average concentration within the first 15 micrometers from the wall.¹⁸ This intense concentration of platelets at artificial surfaces contributes to clot formation on devices and remains one of the persistent engineering challenges in designing implants that contact blood.

One experimental approach to managing this problem involves adding tiny amounts of drag-reducing polymers to blood. These long-chain molecules alter the flow field just enough to reduce the cell-free layer near the wall, which in turn virtually eliminates the near-wall excess of platelet-sized particles.⁷ While still in early stages, this approach illustrates how understanding the physics of margination opens doors to managing its unwanted consequences.

Margination as a Diagnostic Tool

The same physical phenomenon that pushes cells to vessel walls in the body can be harnessed outside the body to sort and isolate rare cells from blood samples. One of the most promising applications involves circulating tumor cell clusters, which are clumps of cancer cells that break off from a tumor and travel through the bloodstream. These clusters are extremely rare, making them difficult to capture, but they are stiffer and larger than normal blood cells, meaning they marginate differently.

A recently developed microfluidic device uses margination combined with secondary flow patterns to continuously separate tumor cell clusters from whole, undiluted blood. The device processes about 1.4 billion cells per second and recovers more than 90 percent of spiked tumor cell clusters from 100 milliliters of blood, with more than 99.9 percent of normal blood components returned.¹⁹ Critically, this method requires no chemical labels or antibodies to identify the target cells. It relies entirely on the physical properties of the cells and the flow dynamics that cause differential margination. This kind of label-free sorting is attractive because it avoids the cost and complexity of antibody-based capture and preserves the cells in their native state for downstream analysis.

The Aging Glycocalyx and Its Implications

The inner surface of blood vessels is coated with a delicate sugar-rich layer called the glycocalyx. This layer acts as a buffer between flowing blood and the endothelial cells lining the vessel, and it plays a role in regulating how cells interact with the wall. With age, this layer thins substantially. Studies comparing young and old mice found that glycocalyx thickness in small vessels was roughly half of what it was in younger animals, and a similar reduction of about a third was observed in the sublingual microcirculation of older humans.²⁰ Along with thinning, the glycocalyx becomes more penetrable, meaning blood cells and plasma components can get closer to the endothelium than they would in a younger vessel.

A thinner, more porous glycocalyx changes the local environment where margination delivers cells to the wall. For white blood cells and platelets, easier access to the endothelial surface could mean more frequent or stronger adhesion events, potentially contributing to the chronic low-grade vascular inflammation that increases with age. For platelet-mediated clotting, a degraded glycocalyx may lower the threshold for thrombus formation. While direct studies linking glycocalyx thinning to altered margination rates in aging humans are still limited, the physical reasoning is straightforward: if the cushion between the flowing blood and the vessel wall erodes, the cells that margination delivers to the near-wall region arrive at a surface that is less protected and more reactive.

The same principle applies in conditions beyond aging. Diabetes, sepsis, and major surgery are all associated with glycocalyx degradation, and each of these conditions also carries elevated risks of thrombosis and excessive inflammation. Understanding margination as a delivery mechanism and the glycocalyx as its gatekeeper helps explain why damage to one amplifies the consequences of the other.